How much weight can I lose by taking Acomplia?

Exhaustive clinical trials conducted with Acomplia on more than 6800 patients yielded substantial results. Patients given Acomplia for a period of one year achieved an average weight loss of six and half kg as compared to just over one and half kg achieved by those on placebo. Most of the weight loss was achieved in the first 9 months of the trial with Acomplia.

Acomplia was also found to reduce the risk of regaining weight. When a group of patients from one of the clinical trials was re-randomized and split into Acomplia and placebo groups, those patients who continued on Acomplia achieved a total weight loss of 7.5 kg over the two year trial period. On the other hand patients who were transferred to placebo achieved a much lower weight loss of only 3.1 kg over the same period.

The best part about Acomplia is that it brings about sizeable reduction in the waist circumference – nearly 6 to 7 cm on an average. This measure is an indication of intra-abdominal fat and is believed to be more important that BMI. If you have a large waist circumference, you should buy Acomplia for reducing it.

Rimonabant acomplia diet weight loss pills are approved now and will be available on sale in all of 25 European  Union Countries in July.

The European Commission gave permission for the sale of Rimonabant acomplia prescription weight loss drugs  to treat obesity and weight loss  with a BMI ( body mass index) of 30 or above as well as for smoking cessation  treatments.

“The approval of Rimonabant Acomplia in the European Union is important news for obese and overweight  patients with additional cardiometabolic risk factors such as type 2 diabetes or dyslipidaemia who will now have  access to an innovative treatment option,” said Sanofi CEO Jean-François Dehecq.